Efficacy and Safety of Linagliptin in Subjects With Long-Standing Type 2 Diabetes Mellitus >10 Years: Evidence From Pooled Data of Randomized, Double-Blind, Placebo-Controlled, Phase III Trials – Clinical Therapeutics

Efficacy and Safety of Linagliptin in Subjects With Long-Standing Type 2 Diabetes Mellitus >10 Years: Evidence From Pooled Data of Randomized, Double-Blind, Placebo-Controlled, Phase III Trials – Clinical Therapeutics.

Advertisements

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s